ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES

EIN: 472231080 501(c)(3) Medical Research

SEATTLE, WA

Total Revenue
$25,521,018
Total Expenses
$32,275,657
Total Assets
$17,386,206
Net Assets
$9,631,305
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2014
Legal Domicile
DE
Principal Officer
JOHN STAMATOYANNOPOULOS
Phone
2062671091
Tax Period
2024-01-01 to 2024-12-31

ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES, founded in 2014, is a mid-sized nonprofit in the Medical Research sector that reported $25.5M in total revenue in fiscal year 2024. Expenses of $32.3M exceeded revenue, resulting in a 26% operating deficit.

Mission

TO ADVANCE THE SCIENCE OF GENE REGULATION FOR THE BENEFIT OF HUMAN HEALTH.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $25,653,464
Program Service Revenue $0
Investment Income $-192,408
Other Revenue $59,962
TOTAL REVENUE $25,521,018

Expense Breakdown

Grants Paid $0
Salaries & Benefits $16,884,234
Fundraising Expenses $0
Program Expenses $25,686,537
Other Expenses $15,391,423
TOTAL EXPENSES $32,275,657

Year-over-Year Comparison

2024 2023 Change
Revenue $25,521,018 $25,796,659 0.0%
Expenses $32,275,657 $35,992,831 -0.1%
Net Income $-6,754,639 $-10,196,172 -0.3%
Key Indicators
✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
4
Independent Members
3
Employees
115
Volunteers
2

Governance Policies

✓ Conflict of Interest Policy
✓ Whistleblower Policy
✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
2
$955,530
Total Directors
6
$1,030,934
Key Employees
0
$0
Highest Compensated
5
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
JOHN STAMATOYANNOPOULOS PRES, SCIENTIFIC DIR., & TREASURER 40.00
Officer Director
$885,000 $58,434 $943,434
HAL DIETZ BOARD MEMBER 1.00
Director
$50,000 $0 $50,000
PETER HANDRINOS BOARD MEMBER THRU 05/24 2.00
Director
$25,000 $0 $25,000
PHILIP GREGORY BOARD MEMBER 2.00
Director
$12,500 $0 $12,500
CHRISTINE DONOHUE BOARD MEMBER 0.50
Director
$0 $0 $0
ERIK INGELSSON BOARD MEMBER THRU 05/24 0.50
Director
$0 $0 $0
THOMAS GROHMAN CORPORATE SECRETARY 1.00
Officer
$12,096 $0 $12,096
ALISTER FUNNELL DEPUTY DIRECTOR 40.00
Highest
$600,000 $57,898 $657,898
MICHAEL COCKRILL CHIEF TECHNOLOGY OFFICER 40.00
Highest
$400,000 $75,576 $475,576
JEFFREY VIERSTRA PRINCIPAL INVESTIGATOR 40.00
Highest
$350,000 $63,184 $413,184
THEO KNIJNENBURG DIRECTOR & FACULTY INVESTIGATOR 40.00
Highest
$325,000 $58,120 $383,120
CHAD LUNDBERG CHIEF OF STAFF THRU 09/24 40.00
Highest
$305,982 $37,642 $343,624
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 $25,521,018 $32,275,657 $17,386,206 $-6,754,639
2023 $25,796,659 $35,992,831 $26,636,898 $-10,196,172
2022 $55,346,565 $54,165,332 $39,729,559 $1,181,233
2021 $44,158,765 $33,064,396 $61,078,390 $11,094,369
2020 $25,217,625 $22,201,302 $20,723,085 $3,016,323
2019 $16,965,373 $20,825,335 $17,764,328 $-3,859,962
2018 $21,469,277 $23,358,445 $19,497,322 $-1,889,168
Explore More Nonprofits
→Top 100 Nonprofits in Washington →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES with other nonprofits in Washington and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.